Cargando…

Editorial: Positron Emission Tomography (PET) Imaging of Brain Biochemistry: Beyond High-Affinity Radioligands

Detalles Bibliográficos
Autores principales:	Kilbourn, Michael R., Scott, Peter J. H., Vasdev, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111736/ https://www.ncbi.nlm.nih.gov/pubmed/35592260 http://dx.doi.org/10.3389/fnins.2022.907460

Ejemplares similares

Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET)
por: Lan, Yu, et al.
Publicado: (2019)

An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates
por: Raval, Nakul Ravi, et al.
Publicado: (2022)

Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
por: Schirrmacher, Ralf, et al.
Publicado: (2019)

Synthesis and Evaluation of a Fluorine-18 Radioligand for Imaging Huntingtin Aggregates by Positron Emission Tomographic Imaging
por: Kaur, Tanpreet, et al.
Publicado: (2021)

[(11)C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)
por: Gourand, Fabienne, et al.
Publicado: (2015)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019)

Positron Emission Tomography (PET) in Oncology
por: Gallamini, Andrea, et al.
Publicado: (2014)

Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy
por: Varlow, Cassis, et al.
Publicado: (2022)

Radiosynthesis and Evaluation of an (18)F-Labeled Positron Emission Tomography (PET) Radioligand for Metabotropic Glutamate Receptor Subtype 4 (mGlu(4))
por: Kil, Kun-Eek, et al.
Publicado: (2014)

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography
por: Dude, Iulia, et al.
Publicado: (2017)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
por: Schröder, Susann, et al.
Publicado: (2016)

Positron Emission Tomography in Animal Models of Tauopathies
por: Cao, Lei, et al.
Publicado: (2022)

Imaging of Reactive Astrogliosis by Positron Emission Tomography
por: Harada, Ryuichi, et al.
Publicado: (2022)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission Tomography
por: Huang, Yangjie, et al.
Publicado: (2020)

Development of Novel (11)C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging
por: Rong, Jian, et al.
Publicado: (2023)

Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-Review
por: Watabe, Tadashi, et al.
Publicado: (2019)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Statistical Parametric Mapping in Amyloid Positron Emission Tomography
por: Smith, Natasha M., et al.
Publicado: (2022)

Editorial: Artificial Intelligence in Positron Emission Tomography
por: Fang, Hanyi, et al.
Publicado: (2022)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
por: Norgaard, Martin, et al.
Publicado: (2022)

Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016
por: Schröder, Susann, et al.
Publicado: (2021)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Positron emission tomography imaging of dementia
por: Small, Gary W.
Publicado: (2000)

Positron Emission Tomography Reveals Abnormal Topological Organization in Functional Brain Network in Diabetic Patients
por: Qiu, Xiangzhe, et al.
Publicado: (2016)

Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2014)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography
por: Sala, Arianna, et al.
Publicado: (2019)

Brain laterality evaluated by F-18 fluorodeoxyglucose positron emission computed tomography in autism spectrum disorders
por: Keeratitanont, Keattichai, et al.
Publicado: (2022)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
por: de Paula Faria, Daniele
Publicado: (2020)

Fluorinated carbohydrates for (18)F-positron emission tomography (PET)
por: Campbell, Emma, et al.
Publicado: (2023)

Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma
por: Chiang, Gloria C., et al.
Publicado: (2018)

Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
por: Tan, Zhiqiang, et al.
Publicado: (2022)

In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
por: Graham, Thomas J. A., et al.
Publicado: (2023)

Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain
por: Fridén, Markus, et al.
Publicado: (2014)

Positron Emission Tomography (PET) Quantification of GABA(A) Receptors in the Brain of Fragile X Patients
por: D’Hulst, Charlotte, et al.
Publicado: (2015)

Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19
por: Ferrucci, Roberta, et al.
Publicado: (2023)

Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography
por: Airas, Laura, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o8vbrb2gcstppsq28d2l6q24vk